Age in months1 | RSV n(%) | HAdV n(%) | HPIV-1 n(%) | HPIV-2 n(%) | HPIV-3 n(%) | hMPV n(%) | FLUAV n(%) | FLUBV n(%) |
---|---|---|---|---|---|---|---|---|
0-6, (n = 184) | 64 (34.8) | 18 (9.7) | 12 (6.5) | 2 (1.08) | 11 (5.9) | 11 (5.9) | 2 (1.08) | 0 (0) |
7-12, (n = 92) | 18 (19.5) | 21 (22.8) | 5 (3.2) | 2 (2.17) | 10 (10.8) | 10 (10.8) | 7 (7.6) | 1 (1.08) |
13-24, (n = 102) | 12 (11.7) | 27 (26.4) | 7 (6.8) | 3 (2.9) | 13 (12.7) | 5 (4.9) | 7 (6.8) | 3 (2.9) |
25-60 , (n = 70) | 13 (18.5) | 17 (24.2) | 6 (8.5) | 7 (10) | 6 (8.5) | 3 (4.2) | 0 (0) | 1 (1.4) |
Total positive (n = 450) 2 | 107 (23.8) | 83 (18.4) | 30 (6.6) | 14 (3.1) | 40 (8.9) | 29 (6.4) | 16 (3.5) | 5 (1.1) |